Mesa Laboratories, Inc.
MLAB
$126.18
$3.853.15%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -179.21% | 378.70% | 717.12% | -41,766.61% | 369.18% |
| Total Depreciation and Amortization | -39.25% | -25.05% | -32.81% | -24.75% | 5.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,237.21% | -58.25% | -44.90% | 16,399.67% | -83.04% |
| Change in Net Operating Assets | 3,559.22% | -342.34% | 70.01% | 325.50% | 97.49% |
| Cash from Operations | 59.85% | -46.08% | 4.97% | 2.91% | 49.46% |
| Capital Expenditure | 27.93% | -182.02% | -230.00% | 47.86% | 31.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -1,510.10% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.99% | -182.02% | -230.00% | 141.52% | -1,123.92% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -8.31% | -48.74% | -908.60% | -91.67% | -12.50% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | 80.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.81% | -0.46% | -0.47% | -0.93% | -0.82% |
| Other Financing Activities | 106.90% | -201.66% | -55.00% | -- | -- |
| Cash from Financing | -117.42% | -54.86% | 4.31% | -194.47% | 784.99% |
| Foreign Exchange rate Adjustments | -138.97% | 390.91% | 74.42% | -32.19% | -29.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.53% | -227.58% | 148.31% | -100.15% | -17.80% |
